Florian Kronenberg MD, MAE
Professor of Genetic Epidemiology, Member of the Academia Europaea, Director of the Institute of Genetic Epidemiology of the Medical University of Innsbruck, Innsbruck, AustriaFlorian Kronenberg received his MD from the University of Innsbruck, Austria. After his training in Medical Genetics in Gerd Utermann's lab, he worked with Roger R. Williams and Steve Hunt at the University of Utah, USA. Later, he headed the Research Unit "Genetic Epidemiology" at the Helmholtz-Center Munich. In 2004, he became full professor and head of the Institute of Genetic Epidemiology at the Medical University of Innsbruck. He is a Member of the Academia Europaea.
His main research interests are genetic and clinical epidemiological studies on lipoprotein(a) as one of the most important genetic risk factors for cardiovascular disease. His team has probably the largest collection of samples with more than 40.000 individuals with in depth characterization of the LPA gene including data from Western blot analyses.
He is Co-Editor of "Atherosclerosis" and served as workgroup member on several guideline and consensus initiatives (K/DOQI, KDIGO and EAS). He chaired the most recent EAS Consensus Statement on Lp(a) (together with Samia Mora and Erik Stroes).
Florian Kronenberg has published roughly 500 papers including 400 original papers and about 90 review articles, editorials and book chapters. He has an H-index of 101 (Scopus) and 119 (Google Scholars) with roughly 58,000 citations.
Disclosures
Work for Advisory Boards/Consulting: Novartis, Amgen, CRISPR Therapeutics, Silence Therapeutics, Roche
Honoraria for lectures: Novartis, Amgen and Daiichi Sankyo